Pharmacokinetic, sedative, and physiological effects of oral compounded formulations of trazodone alone or in combination with gabapentin in male cats
Journal of Veterinary Pharmacology and Therapeutics · 2023
DOI: 10.1111/jvp.13384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2023. Verfasst von Laura E Tucker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada. Hauptthemen laut MEDLINE: Trazodone. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: OVC Pet Trust.
Abstract (Originalsprache)
Trazodone and gabapentin are common oral sedatives in cats, used alone or combined, but no pharmacokinetic studies exist for trazodone in this species. The objective of this study was to determine the pharmacokinetics of oral trazodone (T) alone, or in combination with gabapentin (G) in healthy cats. Cats ( n = 6) were randomly allocated to receive T (3 mg/kg) intravenously (IV), T (5 mg/kg) orally (PO), or T (5 mg/kg) and G (10 mg/kg) PO with a 1‐week washout period between treatments. Heart rate, respiratory rate, indirect blood pressure, and level of sedation were assessed, and venous blood samples were collected serially over 24 h. Analysis of plasma trazodone concentration was performed using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Oral T administration resulted in a bioavailability of 54.9(7–96)%, and 17.2(11–25)% when administered with G. T max 0.17 (0.17–0.5) and 0.17 (0.17–0.75) h; C max 1.67 ± 0.91 and 1.22 ± 0.54 μg/mL, AUC 5.23 (2.0–18.76) and 2.37 (1.17–7.80) h*μg/mL; T 1/2 5.12 ± 2.56 and 4.71 ± 1.07 h; for T and TG, respectively. Sedation was significant when compared to baseline in all groups from 20 or 45 min to 8 h indicating some lag between peak plasma concentration and sedative effects. Physiological variables remained within normal limits. This study concludes that oral trazodone is rapidly absorbed in healthy cats. Addition of gabapentin did not result in more profound sedation, showing no clinical advantage of combining these drugs in this study population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
- Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
- Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
ORCID-Profile: Andrea Sanchez, Alexander Valverde, Jennifer M Reinhart
Förderung
- OVC Pet Trust
Zitieren
APA
Tucker, L. E., Sanchez, A., Valverde, A., Blois, S., Uccello, O., Rutherford, A., Monteith, G., Reinhart, J. M., Keating, S., Gu, Y., & Johnson, R. (2023). Pharmacokinetic, sedative, and physiological effects of oral compounded formulations of trazodone alone or in combination with gabapentin in male cats. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13384
Vancouver
Tucker LE, Sanchez A, Valverde A, Blois S, Uccello O, Rutherford A, et al. Pharmacokinetic, sedative, and physiological effects of oral compounded formulations of trazodone alone or in combination with gabapentin in male cats. Journal of Veterinary Pharmacology and Therapeutics. 2023. doi:10.1111/jvp.13384
BibTeX
@article{Tucker2023,
author = {Tucker, Laura E and Sanchez, Andrea and Valverde, Alexander and Blois, Shauna and Uccello, Olivia and Rutherford, Ashley and Monteith, Gabrielle and Reinhart, Jennifer M and Keating, Stephanie and Gu, Yu and Johnson, Ron},
title = {Pharmacokinetic, sedative, and physiological effects of oral compounded formulations of trazodone alone or in combination with gabapentin in male cats},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2023},
doi = {10.1111/jvp.13384}
}
EUVIMED